USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
SOLULINK BIOSCIENCES
Address:
9853 PACIFIC HEIGHTS BLVD., STE H
SAN DIEGO, CA 92121-
Phone:
N/A
URL:
N/A
EIN:
133091091
DUNS:
065437373
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $750,000.00 2
SBIR Phase II $998,116.00 1

Award List:

Multiplexed vaccine titer test

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$600,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Immunization efforts had all but eliminated childhood diseases such as polio, measles, and mumps by 1990, but the rapid introduction of new vaccines may paradoxically be promoting reemergence as complex injection sched ules decrease compliance by parents and… More

Not Available

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$150,000.00
Agency:
HHS
Principal Investigator:
David Schwartz
Abstract:
The goal of this project is to develop multiple-biomarker imaging for detection of human  papillomavirus (HPV) associated human cancer. Quantum dots (QDs) with multiple emission  colors were chosen as optical probes to label the biomarkers on tissue. Attributeto the unique  optical… More

IGF::OT::IGF OTHER FUNCTIONS RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH), UNIVERSAL REAGENT SETS FOR SENSITIVE AND SPECIFIC MULTIPLEX IMMUNOFLUORESCENT CANCER DIAGNOSTICS

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$998,116.00
Agency:
HHS
Principal Investigator:
David Schwartz – 858-625-0670
Abstract:
Our multiplex IHC assays are aimed to more accurately detect basal-like breast cancer associated iwth lower disease-free survival and overall survival. The goal is to develop an automated assay by incorporating our assay into commercially available automated instruments that stain, scan and analyze… More